The Rainmaker Blueprint is now the governing philosophy, while Citadel Blueprint serves as its commercial and operational application.
CITADEL BLUEPRINT LLC
THE ARCHITECTURE OF ENTERPRISE GROWTH
The Rainmaker Blueprint: Executive Dossier & Strategic Capital Architecture
Stage: Pre-Seed | Pre-Revenue
Valuation Reference: $10,626,000 Independent Fair Market Value
Capital Target: $2,200,000
Primary Commercial Channel: Physical Therapy & Orthopedic Practices
Secondary Expansion Channel: International Territorial Joint-Venture Licensing
Stephen McLeod
Executive Director & Founder
---
I. THE EXECUTIVE THESIS: BUILDING ENTERPRISE VALUE BY DESIGN
Sustainable enterprise growth requires more than a compelling idea, access to capital, or talented personnel. It requires the deliberate integration of intellectual property, financial resources, proprietary technology, strategic relationships, recurring revenue, and disciplined execution.
The most successful enterprise builders understand that these elements should not operate independently. They should reinforce one another, creating a business architecture in which each strategic relationship, capital deployment, technology improvement, and commercial expansion contributes to the long-term value of the enterprise.
This is the foundation of the Rainmaker Blueprint.
Citadel Blueprint LLC is being developed around this philosophy: build the intellectual property, establish the technology infrastructure, secure distribution through strategic partnerships, generate recurring revenue, and expand through capital-efficient commercial channels.
Rather than pursuing growth through ownership of physical infrastructure, the company is engineering a technology platform capable of supporting multiple revenue channels through a common intellectual property foundation.
The objective is not simply to build a product.
It is to build an enterprise whose underlying technology, commercial relationships, recurring revenue, and international licensing opportunities can compound in value over time.
II. THE RAINMAKER BLUEPRINT: THE ARCHITECTURE OF ENTERPRISE GROWTH
The Rainmaker Blueprint integrates five fundamental disciplines.
1. Capital Architecture: Deploy Resources Strategically
Capital is a resource to be allocated, not simply accumulated.
Successful enterprise development requires matching each capital deployment to a specific milestone, measurable objective, and anticipated commercial return.
Citadel's financing strategy reflects this principle through two planned SAFE tranches:
- Initial capital supports technology development, infrastructure, integrations, and pilot deployment.
- Subsequent capital supports commercial rollout, clinic acquisition, and territorial expansion.
The objective is to establish commercial evidence before committing substantial resources to broader deployment.
2. Intellectual Property Architecture: Own the Foundation
The underlying intellectual property represents the enterprise's long-term strategic foundation.
Citadel intends to retain ownership of its core software, algorithms, data architecture, integration pipelines, and proprietary platform infrastructure.
External development partners provide engineering capabilities, implementation expertise, and technical execution without becoming owners of the underlying enterprise platform.
This distinction is fundamental.
A company that owns its intellectual property can license its technology, establish distribution partnerships, and expand into additional markets without surrendering ownership of its central commercial asset.
3. Technology Leverage: One Platform, Multiple Markets
Technology creates leverage when the same underlying infrastructure supports multiple commercial applications.
Citadel's architecture is designed around a common biometric telemetry and intelligence platform.
Domestic physical therapy and orthopedic practices represent the initial commercial channel.
International territorial licensing represents the secondary expansion channel.
Both channels utilize the same underlying technology, allowing improvements in infrastructure, analytics, data integration, and platform functionality to benefit the broader enterprise.
This creates the possibility of expanding revenue without proportionately expanding the company's physical operating footprint.
4. Strategic Relationships: Distribution Through Alignment
Enterprise growth is accelerated when strategic relationships provide capabilities that would otherwise require substantial internal investment.
Technology developers, clinical partners, physical therapy practices, orthopedic groups, trainers, longevity practitioners, and international territorial partners each contribute different components of the commercial ecosystem.
The objective is to structure relationships around clearly defined responsibilities, measurable contributions, and aligned economic incentives.
Rather than building every capability internally, Citadel intends to leverage qualified partners while retaining control of its central technology platform and intellectual property.
5. Performance-Based Economics: Reward Measurable Contributions
Equity and economic incentives should reflect actual enterprise contributions.
Citadel's proposed incentive architecture includes a dedicated 15% strategic equity allocation for qualified advisors, operators, and commercial partners.
Illustrative allocations could include 1% equity grants paired with contractual revenue-sharing arrangements or monthly clinical-volume royalties.
Such incentives would be subject to documented responsibilities, vesting provisions, and measurable performance milestones.
The objective is to preserve founder ownership while attracting individuals and organizations capable of producing measurable commercial results.
The governing principle: Build the foundation. Leverage the relationships. Protect the equity. Reward performance. Scale the enterprise.
III. THE CITADEL PLATFORM: TURNING BIOMETRIC DATA INTO ACTION
Citadel Blueprint is engineering a closed-loop biometric telemetry, physiological profiling, and professional recovery technology platform.
Existing consumer health technology frequently reports historical measurements without creating a structured pathway from measurement to professional intervention and subsequent reassessment.
Citadel's approach is different.
The platform is designed to connect biometric inputs with professional interpretation, individualized intervention, and ongoing measurement.
Its intended professional markets include:
- Physical therapy practices.
- Orthopedic practices.
- Personal training organizations.
- Longevity practitioners.
- Professional recovery and performance facilities.
The platform's biometric architecture incorporates multiple physiological measurements, including:
- Heart rate variability (HRV).
- Autonomic nervous system indicators.
- Cardiovascular recovery.
- DEXA body composition measurements.
- Visceral fat measurements.
- Neuromuscular performance indicators.
These inputs are processed through the platform's developing intelligence architecture to establish individualized physiological profiles and the proprietary Citadel Bio Age / True Metabolic Age™ framework.
The intended operating cycle is:
Measure → Interpret → Intervene → Monitor → Reassess.
The result is a technology platform designed to make biometric information actionable within professional recovery and longevity environments.
Proprietary Technology Components
Pelican Kit
The proposed wearable telemetry system serves as the biometric collection interface.
The hardware strategy emphasizes affordability and accessibility, with an approximately $49 smartwatch serving as a potential low-cost telemetry terminal.
Iron Forge Intelligence Engine
The software intelligence infrastructure is being developed around cloud-based architecture, data processing, API integrations, and analytics.
The proposed technical foundation includes AWS infrastructure, PostgreSQL, Flutter, and GraphQL.
DEXA Integration
DEXA technology provides an additional body composition assessment layer.
Citadel intends to integrate DEXA measurements into its broader physiological profiling system rather than compete with established DEXA equipment manufacturers.
Citadel Academy
The professional education component is designed to develop Advanced Longevity Coaches trained in the interpretation and application of Citadel's assessment framework.
Together, these components form a connected technology and professional services ecosystem.
IV. DUAL REVENUE ARCHITECTURE
Citadel's commercial strategy is built around two complementary revenue engines.
CHANNEL ONE: DOMESTIC RTM REIMBURSEMENT
Physical Therapy & Orthopedic Distribution
The initial commercial strategy targets outpatient physical therapy and orthopedic practices through Remote Therapeutic Monitoring.
The platform is designed to support practitioner workflows involving Medicare-recognized RTM reimbursement codes, subject to applicable coverage, medical necessity, documentation, supervision, and billing requirements.
Relevant CPT codes include:
- 98975: Initial setup and patient education.
- 98977: Remote monitoring device supply for musculoskeletal system monitoring.
- 98980: Initial 20 minutes of monthly treatment management services.
- 98981: Each additional 20 minutes of monthly treatment management services.
Illustrative Unit Economics
Metric| Operating Assumption
Average monthly patient billing| $94
Active monitored patients per clinic| 30
Monthly clinic billing volume| $2,820
Citadel platform revenue share| 30%
Monthly Citadel revenue per clinic| $846
Annual Citadel revenue per clinic| $10,152
These figures represent management assumptions rather than guaranteed reimbursement or realized revenue.
Actual economics will depend on patient eligibility, reimbursement rates, practitioner participation, billing compliance, and executed commercial agreements.
Scaling Potential
The recurring nature of the RTM model provides an opportunity to develop a distributed domestic revenue base.
At the illustrative unit economics above:
- 10 clinics: $101,520 annual platform revenue.
- 50 clinics: $507,600 annual platform revenue.
- 100 clinics: $1,015,200 annual platform revenue.
- 500 clinics: $5,076,000 annual platform revenue.
The strategic objective is to establish a repeatable clinic acquisition and activation process before accelerating nationwide expansion.
CHANNEL TWO: INTERNATIONAL TERRITORIAL LICENSING
Asset-Light Joint-Venture Distribution
The international strategy applies the same underlying technology platform to regional and international markets through territorial licensing and joint-venture arrangements.
Citadel does not intend to finance a network of company-owned international facilities.
Instead, qualified territorial partners would fund local infrastructure, staffing, marketing, and facility operations.
Citadel would provide the underlying technology, licensing rights, implementation support, and ongoing platform infrastructure.
Illustrative Territorial Economics
Revenue Component| Proposed Range
Upfront territorial license| $200,000–$400,000
Localization and implementation| $100,000–$175,000
Annual platform maintenance| $175,000–$300,000
Usage royalties| Tiered, volume-based
The model is designed to generate multiple revenue components from each qualified territorial relationship.
These include initial licensing revenue, implementation revenue, recurring annual platform fees, and ongoing usage-based royalties.
International Expansion Philosophy
The territorial model is intended to follow a disciplined sequence:
Identify → Qualify → License → Localize → Activate → Scale.
Each territory should demonstrate qualified local leadership, adequate financial resources, regulatory readiness, and a credible commercial distribution strategy before deployment.
The objective is to establish an internationally distributable technology platform without assuming the capital burden of international physical expansion.
V. CAPITAL STRUCTURE & STRATEGIC FINANCING
Citadel's financing architecture is designed to support technology development and commercial validation while limiting unnecessary early-stage dilution.
Independent Valuation Reference
Transaction Capital LLC completed an independent valuation with a valuation date of September 30, 2026.
The report established:
Fair Market Value: $10,626,000
The valuation incorporated:
- Guideline Public Company Method: $6.090 million, weighted at 30%.
- Venture Capital Method: $12.570 million, weighted at 70%.
The resulting indicated fair market value was approximately $10.63 million for a 100% controlling, non-marketable ownership interest.
This valuation provides an independent reference point for capital planning and investor discussions. It should not be represented as a guaranteed financing price or evidence of completed commercial validation.
Two-Tranche Financing Strategy
TRANCHE ONE
- Target: $1.10 million.
- SAFE valuation cap: $12 million.
- Primary purpose: Technology development and pilot deployment.
Capital deployment includes:
- AWS infrastructure.
- Core software engineering.
- Biometric telemetry integrations.
- API development.
- HIPAA-oriented security architecture.
- GDPR and international data-protection planning.
- Initial partner deployment.
- Commercial validation.
TRANCHE TWO
- Target: $1.10 million.
- SAFE valuation cap: $13.5 million, if structured as a SAFE.
- Primary purpose: Commercial rollout and expansion.
Capital deployment includes:
- Direct clinic acquisition.
- Practitioner onboarding.
- Platform activation.
- Commercial partnerships.
- Initial international licensing development.
The preferred strategy is to pursue non-dilutive or asset-backed financing for the second tranche where commercially feasible. A second SAFE represents the alternative financing structure.
Total Capital Target: $2.20 Million.
The financing documents will establish the applicable SAFE conversion, dilution, and economic terms.
VI. STRATEGIC PARTNERSHIPS & ENTERPRISE LEVERAGE
The Rainmaker Blueprint recognizes that enterprise value is created not only through internally developed capabilities but also through the strategic integration of outside expertise.
Citadel's proposed partnership architecture includes several categories.
Technology Development Partners
Responsible for engineering, cloud infrastructure, software development, telemetry integrations, and technical scalability.
All ownership and licensing rights must be documented contractually to preserve Citadel's intended intellectual property ownership.
Clinical Distribution Partners
Physical therapy and orthopedic organizations provide access to qualified practitioners and potential patient populations.
The objective is to establish repeatable deployment arrangements supported by appropriate clinical workflows and reimbursement compliance.
Professional Recovery Partners
Personal trainers, longevity practitioners, and qualified recovery professionals contribute to the broader assessment and intervention ecosystem.
International Territorial Partners
Qualified regional partners provide local financial resources, facilities, staffing, marketing, and distribution capabilities.
Strategic Advisors & Commercial Rainmakers
Individuals who generate measurable enterprise value may participate through contractual compensation, performance-based royalties, and appropriately structured equity incentives.
The central principle is that economic participation should correspond to actual contributions rather than titles or anticipated influence.
VII. REGULATORY DISCIPLINE & RISK MANAGEMENT
Technology-enabled healthcare requires disciplined regulatory positioning.
Citadel's development strategy is designed to distinguish between biometric information collection, wellness applications, professional recovery workflows, and regulated medical-device functions.
The company intends to build privacy and security considerations into its architecture from inception.
Key areas include:
HIPAA: Appropriate administrative, technical, and contractual safeguards when handling protected health information on behalf of covered entities or business associates.
GDPR: Appropriate privacy, consent, processing, and data-subject protections for applicable European markets.
RTM Compliance: Appropriate practitioner involvement, patient eligibility, documentation, device requirements, time thresholds, and reimbursement procedures.
FDA Considerations: Evaluation of intended-use claims, software functionality, hardware classification, and any applicable medical-device requirements.
Importantly, describing a product as wellness technology does not automatically exempt it from FDA oversight. Regulatory classification must reflect the actual intended use and functionality.
The objective is to establish a scalable compliance framework without making premature medical-device or reimbursement claims.
VIII. EXECUTION ROADMAP
The execution strategy follows a staged deployment model.
PHASE ONE: TECHNICAL FOUNDATION & PILOT
Months 1–4
- Complete core AWS infrastructure.
- Develop the initial intelligence engine.
- Finalize Pelican telemetry integrations.
- Establish data architecture and security controls.
- Integrate initial assessment functionality.
- Activate the first qualified pilot relationships.
Primary objective: Demonstrate that the core platform functions as intended in a controlled deployment environment.
PHASE TWO: DOMESTIC COMMERCIALIZATION
Months 5–8
- Expand physical therapy and orthopedic outreach.
- Establish practitioner onboarding procedures.
- Validate patient activation and retention.
- Test RTM workflows and documentation.
- Measure actual clinic-level economics.
- Establish repeatable commercial acquisition processes.
Primary objective: Demonstrate commercial viability and repeatability.
PHASE THREE: TERRITORIAL LICENSING
Months 9–12+
- Identify qualified international partners.
- Establish territorial licensing agreements.
- Complete localization and regulatory assessments.
- Implement initial international deployments.
- Establish recurring licensing and usage-fee structures.
Primary objective: Demonstrate that the same technology infrastructure can support international distribution without requiring Citadel to finance overseas facilities.
The timing represents management targets, not completed milestones or guaranteed deployment dates.
IX. ENTERPRISE VALUE CREATION: THE COMPOUNDING EFFECT
The ultimate objective is to create an enterprise in which individual strategic components reinforce one another.
Intellectual property creates ownership and licensing opportunities.
Technology creates operational leverage.
Strategic partnerships create distribution.
Domestic RTM establishes a potential recurring commercial foundation.
International territorial licensing introduces additional revenue opportunities without requiring proportional physical infrastructure investment.
Performance-based economics attract qualified contributors while preserving founder ownership.
Capital discipline supports development without unnecessary dilution.
The combined architecture creates a potential compounding effect.
As the platform develops, improvements in technology can benefit domestic and international markets simultaneously.
As distribution expands, the same intellectual property can support additional customers and territories.
As recurring revenue develops, the enterprise can reinvest in technology, infrastructure, and commercial expansion.
This is the distinction between building a collection of individual business activities and engineering a scalable enterprise.
Independent Valuation & Long-Term Financial Scenarios
Citadel's September 30, 2026 Transaction Capital valuation provides the current independent fair market value reference of $10.626 million.
The associated management forecast incorporates several potential future operating outcomes.
Scenario| 2031 Revenue| Enterprise Value
High Success| $116.28M| $319.69M
Base Case| $57.20M| $125.84M
Downside| $22.68M| $39.91M
Failure| —| $0
These are scenario-based management projections incorporated into the valuation analysis, not guaranteed outcomes or independently verified future enterprise values.
The distinction is important: the present valuation provides a current reference point, while the future scenarios illustrate potential outcomes contingent upon execution, financing, adoption, and commercial performance.
X. THE FOUNDER'S OPERATING STANDARD
The architecture of enterprise growth ultimately depends on the discipline of the people responsible for executing it.
The Rainmaker philosophy is built around several operating principles:
Think Architecturally. Understand how individual decisions affect the larger enterprise.
Allocate Capital Intelligently. Direct resources toward measurable objectives rather than unnecessary overhead.
Own the Foundation. Preserve control of intellectual property, technology, and the central commercial platform.
Leverage Relationships. Build partnerships that extend capabilities and accelerate distribution.
Reward Performance. Align compensation and ownership with measurable contributions.
Validate Before Scaling. Establish operational evidence before committing substantial expansion capital.
Preserve Optionality. Maintain flexibility in financing, commercial partnerships, and international deployment.
Build for Durability. Prioritize recurring revenue, scalable infrastructure, and long-term enterprise value over short-term appearances of growth.
The objective is not to imitate another company's playbook.
It is to understand the principles that have consistently created successful enterprises, integrate those principles into a coherent operating philosophy, and apply them through disciplined execution.
---
THE CITADEL BLUEPRINT
DEMAND FIRST. DEPLOYMENT SECOND. SCALE THIRD.
One proprietary technology foundation.
Two complementary revenue engines.
Strategic partnerships aligned around measurable performance.
A disciplined capital structure.
An asset-light international expansion strategy.
The architecture is designed to turn intellectual property into technology, technology into distribution, distribution into recurring revenue, and recurring revenue into enterprise value.
That is the Rainmaker Blueprint.
That is the strategic foundation of Citadel Blueprint LLC.
---
Stephen McLeod
Executive Director & Founder
Citadel Blueprint LLC
SM Investigation Group — CFE
West Palm Beach, Florida
561-729-5304
www.sminvestigator.com
www.sminvestigationgroup.comMy final assessment
CITADEL BLUEPRINT LLC
THE ARCHITECTURE OF ENTERPRISE GROWTH
The Rainmaker Blueprint: Executive Dossier & Strategic Capital Architecture
Stage: Pre-Seed | Pre-Revenue
Valuation Reference: $10,626,000 Independent Fair Market Value
Capital Target: $2,200,000
Primary Commercial Channel: Physical Therapy & Orthopedic Practices
Secondary Expansion Channel: International Territorial Joint-Venture Licensing
Stephen McLeod
Executive Director & Founder
---
I. THE EXECUTIVE THESIS: BUILDING ENTERPRISE VALUE BY DESIGN
Sustainable enterprise growth requires more than a compelling idea, access to capital, or talented personnel. It requires the deliberate integration of intellectual property, financial resources, proprietary technology, strategic relationships, recurring revenue, and disciplined execution.
The most successful enterprise builders understand that these elements should not operate independently. They should reinforce one another, creating a business architecture in which each strategic relationship, capital deployment, technology improvement, and commercial expansion contributes to the long-term value of the enterprise.
This is the foundation of the Rainmaker Blueprint.
Citadel Blueprint LLC is being developed around this philosophy: build the intellectual property, establish the technology infrastructure, secure distribution through strategic partnerships, generate recurring revenue, and expand through capital-efficient commercial channels.
Rather than pursuing growth through ownership of physical infrastructure, the company is engineering a technology platform capable of supporting multiple revenue channels through a common intellectual property foundation.
The objective is not simply to build a product.
It is to build an enterprise whose underlying technology, commercial relationships, recurring revenue, and international licensing opportunities can compound in value over time.
II. THE RAINMAKER BLUEPRINT: THE ARCHITECTURE OF ENTERPRISE GROWTH
The Rainmaker Blueprint integrates five fundamental disciplines.
1. Capital Architecture: Deploy Resources Strategically
Capital is a resource to be allocated, not simply accumulated.
Successful enterprise development requires matching each capital deployment to a specific milestone, measurable objective, and anticipated commercial return.
Citadel's financing strategy reflects this principle through two planned SAFE tranches:
- Initial capital supports technology development, infrastructure, integrations, and pilot deployment.
- Subsequent capital supports commercial rollout, clinic acquisition, and territorial expansion.
The objective is to establish commercial evidence before committing substantial resources to broader deployment.
2. Intellectual Property Architecture: Own the Foundation
The underlying intellectual property represents the enterprise's long-term strategic foundation.
Citadel intends to retain ownership of its core software, algorithms, data architecture, integration pipelines, and proprietary platform infrastructure.
External development partners provide engineering capabilities, implementation expertise, and technical execution without becoming owners of the underlying enterprise platform.
This distinction is fundamental.
A company that owns its intellectual property can license its technology, establish distribution partnerships, and expand into additional markets without surrendering ownership of its central commercial asset.
3. Technology Leverage: One Platform, Multiple Markets
Technology creates leverage when the same underlying infrastructure supports multiple commercial applications.
Citadel's architecture is designed around a common biometric telemetry and intelligence platform.
Domestic physical therapy and orthopedic practices represent the initial commercial channel.
International territorial licensing represents the secondary expansion channel.
Both channels utilize the same underlying technology, allowing improvements in infrastructure, analytics, data integration, and platform functionality to benefit the broader enterprise.
This creates the possibility of expanding revenue without proportionately expanding the company's physical operating footprint.
4. Strategic Relationships: Distribution Through Alignment
Enterprise growth is accelerated when strategic relationships provide capabilities that would otherwise require substantial internal investment.
Technology developers, clinical partners, physical therapy practices, orthopedic groups, trainers, longevity practitioners, and international territorial partners each contribute different components of the commercial ecosystem.
The objective is to structure relationships around clearly defined responsibilities, measurable contributions, and aligned economic incentives.
Rather than building every capability internally, Citadel intends to leverage qualified partners while retaining control of its central technology platform and intellectual property.
5. Performance-Based Economics: Reward Measurable Contributions
Equity and economic incentives should reflect actual enterprise contributions.
Citadel's proposed incentive architecture includes a dedicated 15% strategic equity allocation for qualified advisors, operators, and commercial partners.
Illustrative allocations could include 1% equity grants paired with contractual revenue-sharing arrangements or monthly clinical-volume royalties.
Such incentives would be subject to documented responsibilities, vesting provisions, and measurable performance milestones.
The objective is to preserve founder ownership while attracting individuals and organizations capable of producing measurable commercial results.
The governing principle: Build the foundation. Leverage the relationships. Protect the equity. Reward performance. Scale the enterprise.
III. THE CITADEL PLATFORM: TURNING BIOMETRIC DATA INTO ACTION
Citadel Blueprint is engineering a closed-loop biometric telemetry, physiological profiling, and professional recovery technology platform.
Existing consumer health technology frequently reports historical measurements without creating a structured pathway from measurement to professional intervention and subsequent reassessment.
Citadel's approach is different.
The platform is designed to connect biometric inputs with professional interpretation, individualized intervention, and ongoing measurement.
Its intended professional markets include:
- Physical therapy practices.
- Orthopedic practices.
- Personal training organizations.
- Longevity practitioners.
- Professional recovery and performance facilities.
The platform's biometric architecture incorporates multiple physiological measurements, including:
- Heart rate variability (HRV).
- Autonomic nervous system indicators.
- Cardiovascular recovery.
- DEXA body composition measurements.
- Visceral fat measurements.
- Neuromuscular performance indicators.
These inputs are processed through the platform's developing intelligence architecture to establish individualized physiological profiles and the proprietary Citadel Bio Age / True Metabolic Age™ framework.
The intended operating cycle is:
Measure → Interpret → Intervene → Monitor → Reassess.
The result is a technology platform designed to make biometric information actionable within professional recovery and longevity environments.
Proprietary Technology Components
Pelican Kit
The proposed wearable telemetry system serves as the biometric collection interface.
The hardware strategy emphasizes affordability and accessibility, with an approximately $49 smartwatch serving as a potential low-cost telemetry terminal.
Iron Forge Intelligence Engine
The software intelligence infrastructure is being developed around cloud-based architecture, data processing, API integrations, and analytics.
The proposed technical foundation includes AWS infrastructure, PostgreSQL, Flutter, and GraphQL.
DEXA Integration
DEXA technology provides an additional body composition assessment layer.
Citadel intends to integrate DEXA measurements into its broader physiological profiling system rather than compete with established DEXA equipment manufacturers.
Citadel Academy
The professional education component is designed to develop Advanced Longevity Coaches trained in the interpretation and application of Citadel's assessment framework.
Together, these components form a connected technology and professional services ecosystem.
IV. DUAL REVENUE ARCHITECTURE
Citadel's commercial strategy is built around two complementary revenue engines.
CHANNEL ONE: DOMESTIC RTM REIMBURSEMENT
Physical Therapy & Orthopedic Distribution
The initial commercial strategy targets outpatient physical therapy and orthopedic practices through Remote Therapeutic Monitoring.
The platform is designed to support practitioner workflows involving Medicare-recognized RTM reimbursement codes, subject to applicable coverage, medical necessity, documentation, supervision, and billing requirements.
Relevant CPT codes include:
- 98975: Initial setup and patient education.
- 98977: Remote monitoring device supply for musculoskeletal system monitoring.
- 98980: Initial 20 minutes of monthly treatment management services.
- 98981: Each additional 20 minutes of monthly treatment management services.
Illustrative Unit Economics
Metric| Operating Assumption
Average monthly patient billing| $94
Active monitored patients per clinic| 30
Monthly clinic billing volume| $2,820
Citadel platform revenue share| 30%
Monthly Citadel revenue per clinic| $846
Annual Citadel revenue per clinic| $10,152
These figures represent management assumptions rather than guaranteed reimbursement or realized revenue.
Actual economics will depend on patient eligibility, reimbursement rates, practitioner participation, billing compliance, and executed commercial agreements.
Scaling Potential
The recurring nature of the RTM model provides an opportunity to develop a distributed domestic revenue base.
At the illustrative unit economics above:
- 10 clinics: $101,520 annual platform revenue.
- 50 clinics: $507,600 annual platform revenue.
- 100 clinics: $1,015,200 annual platform revenue.
- 500 clinics: $5,076,000 annual platform revenue.
The strategic objective is to establish a repeatable clinic acquisition and activation process before accelerating nationwide expansion.
CHANNEL TWO: INTERNATIONAL TERRITORIAL LICENSING
Asset-Light Joint-Venture Distribution
The international strategy applies the same underlying technology platform to regional and international markets through territorial licensing and joint-venture arrangements.
Citadel does not intend to finance a network of company-owned international facilities.
Instead, qualified territorial partners would fund local infrastructure, staffing, marketing, and facility operations.
Citadel would provide the underlying technology, licensing rights, implementation support, and ongoing platform infrastructure.
Illustrative Territorial Economics
Revenue Component| Proposed Range
Upfront territorial license| $200,000–$400,000
Localization and implementation| $100,000–$175,000
Annual platform maintenance| $175,000–$300,000
Usage royalties| Tiered, volume-based
The model is designed to generate multiple revenue components from each qualified territorial relationship.
These include initial licensing revenue, implementation revenue, recurring annual platform fees, and ongoing usage-based royalties.
International Expansion Philosophy
The territorial model is intended to follow a disciplined sequence:
Identify → Qualify → License → Localize → Activate → Scale.
Each territory should demonstrate qualified local leadership, adequate financial resources, regulatory readiness, and a credible commercial distribution strategy before deployment.
The objective is to establish an internationally distributable technology platform without assuming the capital burden of international physical expansion.
V. CAPITAL STRUCTURE & STRATEGIC FINANCING
Citadel's financing architecture is designed to support technology development and commercial validation while limiting unnecessary early-stage dilution.
Independent Valuation Reference
Transaction Capital LLC completed an independent valuation with a valuation date of September 30, 2026.
The report established:
Fair Market Value: $10,626,000
The valuation incorporated:
- Guideline Public Company Method: $6.090 million, weighted at 30%.
- Venture Capital Method: $12.570 million, weighted at 70%.
The resulting indicated fair market value was approximately $10.63 million for a 100% controlling, non-marketable ownership interest.
This valuation provides an independent reference point for capital planning and investor discussions. It should not be represented as a guaranteed financing price or evidence of completed commercial validation.
Two-Tranche Financing Strategy
TRANCHE ONE
- Target: $1.10 million.
- SAFE valuation cap: $12 million.
- Primary purpose: Technology development and pilot deployment.
Capital deployment includes:
- AWS infrastructure.
- Core software engineering.
- Biometric telemetry integrations.
- API development.
- HIPAA-oriented security architecture.
- GDPR and international data-protection planning.
- Initial partner deployment.
- Commercial validation.
TRANCHE TWO
- Target: $1.10 million.
- SAFE valuation cap: $13.5 million, if structured as a SAFE.
- Primary purpose: Commercial rollout and expansion.
Capital deployment includes:
- Direct clinic acquisition.
- Practitioner onboarding.
- Platform activation.
- Commercial partnerships.
- Initial international licensing development.
The preferred strategy is to pursue non-dilutive or asset-backed financing for the second tranche where commercially feasible. A second SAFE represents the alternative financing structure.
Total Capital Target: $2.20 Million.
The financing documents will establish the applicable SAFE conversion, dilution, and economic terms.
VI. STRATEGIC PARTNERSHIPS & ENTERPRISE LEVERAGE
The Rainmaker Blueprint recognizes that enterprise value is created not only through internally developed capabilities but also through the strategic integration of outside expertise.
Citadel's proposed partnership architecture includes several categories.
Technology Development Partners
Responsible for engineering, cloud infrastructure, software development, telemetry integrations, and technical scalability.
All ownership and licensing rights must be documented contractually to preserve Citadel's intended intellectual property ownership.
Clinical Distribution Partners
Physical therapy and orthopedic organizations provide access to qualified practitioners and potential patient populations.
The objective is to establish repeatable deployment arrangements supported by appropriate clinical workflows and reimbursement compliance.
Professional Recovery Partners
Personal trainers, longevity practitioners, and qualified recovery professionals contribute to the broader assessment and intervention ecosystem.
International Territorial Partners
Qualified regional partners provide local financial resources, facilities, staffing, marketing, and distribution capabilities.
Strategic Advisors & Commercial Rainmakers
Individuals who generate measurable enterprise value may participate through contractual compensation, performance-based royalties, and appropriately structured equity incentives.
The central principle is that economic participation should correspond to actual contributions rather than titles or anticipated influence.
VII. REGULATORY DISCIPLINE & RISK MANAGEMENT
Technology-enabled healthcare requires disciplined regulatory positioning.
Citadel's development strategy is designed to distinguish between biometric information collection, wellness applications, professional recovery workflows, and regulated medical-device functions.
The company intends to build privacy and security considerations into its architecture from inception.
Key areas include:
HIPAA: Appropriate administrative, technical, and contractual safeguards when handling protected health information on behalf of covered entities or business associates.
GDPR: Appropriate privacy, consent, processing, and data-subject protections for applicable European markets.
RTM Compliance: Appropriate practitioner involvement, patient eligibility, documentation, device requirements, time thresholds, and reimbursement procedures.
FDA Considerations: Evaluation of intended-use claims, software functionality, hardware classification, and any applicable medical-device requirements.
Importantly, describing a product as wellness technology does not automatically exempt it from FDA oversight. Regulatory classification must reflect the actual intended use and functionality.
The objective is to establish a scalable compliance framework without making premature medical-device or reimbursement claims.
VIII. EXECUTION ROADMAP
The execution strategy follows a staged deployment model.
PHASE ONE: TECHNICAL FOUNDATION & PILOT
Months 1–4
- Complete core AWS infrastructure.
- Develop the initial intelligence engine.
- Finalize Pelican telemetry integrations.
- Establish data architecture and security controls.
- Integrate initial assessment functionality.
- Activate the first qualified pilot relationships.
Primary objective: Demonstrate that the core platform functions as intended in a controlled deployment environment.
PHASE TWO: DOMESTIC COMMERCIALIZATION
Months 5–8
- Expand physical therapy and orthopedic outreach.
- Establish practitioner onboarding procedures.
- Validate patient activation and retention.
- Test RTM workflows and documentation.
- Measure actual clinic-level economics.
- Establish repeatable commercial acquisition processes.
Primary objective: Demonstrate commercial viability and repeatability.
PHASE THREE: TERRITORIAL LICENSING
Months 9–12+
- Identify qualified international partners.
- Establish territorial licensing agreements.
- Complete localization and regulatory assessments.
- Implement initial international deployments.
- Establish recurring licensing and usage-fee structures.
Primary objective: Demonstrate that the same technology infrastructure can support international distribution without requiring Citadel to finance overseas facilities.
The timing represents management targets, not completed milestones or guaranteed deployment dates.
IX. ENTERPRISE VALUE CREATION: THE COMPOUNDING EFFECT
The ultimate objective is to create an enterprise in which individual strategic components reinforce one another.
Intellectual property creates ownership and licensing opportunities.
Technology creates operational leverage.
Strategic partnerships create distribution.
Domestic RTM establishes a potential recurring commercial foundation.
International territorial licensing introduces additional revenue opportunities without requiring proportional physical infrastructure investment.
Performance-based economics attract qualified contributors while preserving founder ownership.
Capital discipline supports development without unnecessary dilution.
The combined architecture creates a potential compounding effect.
As the platform develops, improvements in technology can benefit domestic and international markets simultaneously.
As distribution expands, the same intellectual property can support additional customers and territories.
As recurring revenue develops, the enterprise can reinvest in technology, infrastructure, and commercial expansion.
This is the distinction between building a collection of individual business activities and engineering a scalable enterprise.
Independent Valuation & Long-Term Financial Scenarios
Citadel's September 30, 2026 Transaction Capital valuation provides the current independent fair market value reference of $10.626 million.
The associated management forecast incorporates several potential future operating outcomes.
Scenario| 2031 Revenue| Enterprise Value
High Success| $116.28M| $319.69M
Base Case| $57.20M| $125.84M
Downside| $22.68M| $39.91M
Failure| —| $0
These are scenario-based management projections incorporated into the valuation analysis, not guaranteed outcomes or independently verified future enterprise values.
The distinction is important: the present valuation provides a current reference point, while the future scenarios illustrate potential outcomes contingent upon execution, financing, adoption, and commercial performance.
X. THE FOUNDER'S OPERATING STANDARD
The architecture of enterprise growth ultimately depends on the discipline of the people responsible for executing it.
The Rainmaker philosophy is built around several operating principles:
Think Architecturally. Understand how individual decisions affect the larger enterprise.
Allocate Capital Intelligently. Direct resources toward measurable objectives rather than unnecessary overhead.
Own the Foundation. Preserve control of intellectual property, technology, and the central commercial platform.
Leverage Relationships. Build partnerships that extend capabilities and accelerate distribution.
Reward Performance. Align compensation and ownership with measurable contributions.
Validate Before Scaling. Establish operational evidence before committing substantial expansion capital.
Preserve Optionality. Maintain flexibility in financing, commercial partnerships, and international deployment.
Build for Durability. Prioritize recurring revenue, scalable infrastructure, and long-term enterprise value over short-term appearances of growth.
The objective is not to imitate another company's playbook.
It is to understand the principles that have consistently created successful enterprises, integrate those principles into a coherent operating philosophy, and apply them through disciplined execution.
---
THE CITADEL BLUEPRINT
DEMAND FIRST. DEPLOYMENT SECOND. SCALE THIRD.
One proprietary technology foundation.
Two complementary revenue engines.
Strategic partnerships aligned around measurable performance.
A disciplined capital structure.
An asset-light international expansion strategy.
The architecture is designed to turn intellectual property into technology, technology into distribution, distribution into recurring revenue, and recurring revenue into enterprise value.
That is the Rainmaker Blueprint.
That is the strategic foundation of Citadel Blueprint LLC.
---
Stephen McLeod
Executive Director & Founder
Citadel Blueprint LLC
SM Investigation Group — CFE
West Palm Beach, Florida
561-729-5304
www.sminvestigator.com
www.sminvestigationgroup.comMy final assessment
